skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Would you please give me your evaluation of FLGT's recent quarter. On the surface it appears quite positive, however the stock is down 10%. Was it their guidance that turned the market sour? I am also perplexed - they state they carry $28/share in cash and marketable securities yet the stock is trading at $23 implying that when you strip out cash the business is worth NEGATIVE $148,000,000. Does this mean the market believes something is fundamentally wrong with the business and/or management? Finally, as a shareholder should I be running for the hills or is this a case of the market mispricing an asset?

Many thanks
Scott
Read Answer Asked by Scott on March 01, 2024
Q: hi all: LMAT

lamaitre vascular

can you give me your input and outlook for this one?

thanks in advance

Read Answer Asked by Robert on March 01, 2024
Q: From your point of view, what are the pros and cons of Buffett's preferred ''operating earnings'' metric versus industry-conventionn ''net earnings''?

Thanks
Read Answer Asked by Daniel on March 01, 2024
Q: What is the best etf or mutual fund to invest in India? As well do you think it is a good area to invest in right now?
Read Answer Asked by Gary on March 01, 2024
Q: Hello, you recommended UnitedHealth Group Inc. (UNH) in the past. The recent launch of an antitrust investigation against UNH has led to a sudden drop in the stock price. I’m curious about your thoughts on this investigation. Do you believe it will cause any damage to the company? And considering the circumstances, do you still consider UNH a good buy? Thank you!
Read Answer Asked by Esther on March 01, 2024
Q: Do you consider the dividend streams from the above companies to be safe? Do you forsee issues with even moderate growth for the companies as they say they are diversifying ( cough ). thanks al
Read Answer Asked by alex on March 01, 2024
Q: How would you rate ILMN overall since 2024? Is it still a takeover target in your estimation and who would be the top ones that would make most sense to acquire ILMN?
Read Answer Asked by MG on March 01, 2024
Q: Hi 5i, this company recently tried to sell itself and there were no takers. They now have decided to let go of 25% of the workforce and buy up to 150 million dollars of shares back.

Looks like they will be cash flow positive by next quarter and are starting to get better traction on selling the drug.

The drug patent is for dosing as the chemical composition expires in a couple years. How would you value this company and would you rate it a buy hold or sell.
Read Answer Asked by Mark on March 01, 2024
Q: Hi. Follow-up on your previous EQB good results quarter question. Being a rookie investor I just don’t understand after such a good quarterly report why the stock went on sale down $9.99 at one time today. Can you explain in plain layman’s term why or at least give a guess why such a big drop? If this report would have been horrible does that mean the price would have jumped? Just when I thought I knew how the game worked this change has added some confusion to my thought process. Thanks again for all that you’se guys do for us amateurs. Ken. :-)
Read Answer Asked by Ken on March 01, 2024
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!